The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis-Reference-Cited by-同舟云学术

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Published:2003-05 Issue:1 Volume:61 Page:19-30
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Miller T.J.,Zipursky R.B.,Perkins D.,Addington J.,Woods S.W.,Hawkins K.A.,Hoffman R.,Preda A.,Epstein I.,Addington D.,Lindborg S.,Marquez E.,Tohen M.,Breier A.,McGlashan T.H.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference24 articles.

1. Study of chronic schizophrenics with positive and negative family histories of psychosis;Alda;Acta Psychiatr. Scand.,1991

2. Diagnostic and Statistical Manual of Mental Disorders,1994

3. Quality of life in the evaluation of community support systems;Baker;Eval. Program Plann.,1982

4. Gender differences in affective, schizoaffective, and schizophrenic disorders: a review;Bardenstein;Schizophr. Res.,1990

5. Measurement of premorbid adjustment in chronic schizophrenia;Cannon-Spoor;Schizophr. Bull.,1982

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosis;Psychiatry Research;2024-11

2. A mixed-methods study to evaluate the feasibility and preliminary efficacy of delivering the optimal health program (OHP) for youth at clinical high risk (CHR) for psychosis: A study protocol;PLOS ONE;2024-07-18

3. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders;Cochrane Database of Systematic Reviews;2024-07-03

4. Excessive interstitial free-water in cortical gray matter preceding accelerated volume changes in individuals at clinical high risk for psychosis;Molecular Psychiatry;2024-06-03

5. Microstructural Cortical Gray Matter Changes Preceding Accelerated Volume Changes in Individuals at Clinical High Risk for Psychosis;2023-09-28